Skip to main content
. 2016 Jun 29;7(31):50150–50160. doi: 10.18632/oncotarget.10322

Table 1. Characteristics of PDX tumors and their corresponding CRC patients.

PDX histology Pathology Preoperative chemotherapy TNMa Mouse strain Days for growthb
KUC1 CRCc mod.c None pT3 pN1 cM1 NOD/SCID 75
KUC2 CRC mod. None pT4a pN0 cM1 NOD/SCID 30
KUC3 No tumor mod. None pT4a pN2 cM0 NOD/SCID -
KUC4 DLBCLc mod. Noned pT2 pN0 cM0 NOD/SCID 28
KUC5 CRC mod. None pT3 pN0 cM1 NOD/SCID 176
KUC6 CRC mod. None pT3 pN1 cM0 NSG 223
KUC7 CRC mod. None pT2 pN0 cM0 NSG 35
KUC8 CRC mod. None pT4a pN1 cM1 NSG 47
KUC9 CRC mod. None pT4b pN0 cM0 NSG 19
KUC10 No tumor mod. None pT3 pN0 cM0 NSG -
KUC11 DLBCL well.c None pT3 pN1 cM0 NSG 55
KUC12 No tumor well. None pT3 pN1 cM1 NSG -
KUC13 No tumor mod. Yes pT3 pN2 cM1 NSG -
a

TNM classification (7th edition) in clinical pathological reports.

b

Number of days when PDX tumor reached 0.5 cm3 after xenotransplantation of patient specimen.

c

Abbreviations: CRC, colorectal cancer; DLBCL, diffuse large B cell lymphoma; mod, moderately-differentiated adenocarcinoma; well, well-differentiated adenocarcinoma.

d

None, but under an immunosuppressive therapy after organ transplantation.